What they found
4-Phenylbutyric acid (4PBA), a chemical chaperone, rescued cell surface localization of a missense-mutated membrane protein (DSCAML1 A2105T) that was trapped intracellularly. In a knock-in mouse model, oral 4PBA administration corrected dendritic retraction, hippocampal interneuron clustering deficits, and reduced epileptic spike-and-wave discharges. This is an in vivo proof-of-concept that a chemical chaperone can rescue trafficking of a missense-mutated extracellular protein.
Lateral connection
Stereocilin (STRC) is an extracellular protein that must traffic to the hair bundle surface. Misha’s maternal E1659A missense mutation likely causes misfolding or mistrafficking analogous to DSCAML1 A2105T. This paper demonstrates that a generic chemical chaperone (4PBA) can rescue surface localization of a patient-specific missense mutation in vivo — the exact therapeutic strategy of the STRC Pharmacochaperone campaign. The fact that oral administration was sufficient is encouraging for clinical translation feasibility.
Hypothesis suggested
A pharmacological chaperone (potentially 4PBA itself, or a more specific compound from our virtual screen) could rescue STRC E1659A trafficking to the stereocilia surface. Maps directly to STRC Pharmacochaperone Virtual Screen E1659A (S-tier). Testable: does 4PBA restore STRC E1659A surface expression in a heterologous cell system?
What could be computed
Molecular dynamics comparison of STRC E1659A misfolding trajectory vs. DSCAML1 A2105T. Docking of 4PBA to the STRC E1659A predicted misfolded intermediate. Free energy perturbation of 4PBA binding to STRC vs. our current salicylic acid / indole-3-acetic acid lead compounds.
Links
Connections
[part-of]h01 hub[source]auto-indexed 2026-04-21 by strc-lit-watch